New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill AR38

Introduced
1/11/22  

Caption

Recognizes October 13, 2020 as "Metastatic Breast Cancer Awareness Day" in New Jersey.

Impact

By officially recognizing this day, the resolution seeks to engage the public in discussions about metastatic breast cancer and to promote the importance of research and treatment options available for patients. The resolution illustrates the commitment of New Jersey’s legislature to improving cancer awareness and potentially influencing funding and support for research initiatives. The state's participation in initiatives like the #LightUPMBC campaign is also encouraged, furthering the objective of raising awareness.

Summary

Assembly Resolution AR38 designates October 13, 2020, as 'Metastatic Breast Cancer Awareness Day' in New Jersey. The resolution aims to raise public awareness about metastatic breast cancer, a condition that occurs when cancer spreads from the breast to other parts of the body, which is often incurable and significantly impacts the life expectancy of affected patients. The resolution also highlights the need for increased focus on research for the treatment of metastatic cases, which causes the majority of breast cancer deaths.

Contention

While the resolution itself is largely symbolic, it underscores significant issues surrounding breast cancer treatment disparities and the urgent need for more research funding, especially as the statistics regarding mortality rates differ based on race, with African American individuals facing higher mortality rates from the disease. There is no opposition mentioned for this specific resolution, but the context suggests that discussions around funding and research priorities in cancer treatment could lead to broader conversations within healthcare legislation.

Companion Bills

No companion bills found.

Previously Filed As

NJ HR49

Designating October 13, 2025, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.

NJ HR514

Designating October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.

NJ SR175

Designating October 13, 2025, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.

NJ SR256

Designating October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.

NJ SR160

Recognizing the month of October 2025 as "National Breast Cancer Awareness Month" and October 17, 2025, as "National Mammography Day" in Pennsylvania.

NJ HR199

Recognizing the month of October 2025 as "Breast Cancer Awareness Month" and October 17, 2025, as "National Mammography Day" in Pennsylvania.

NJ HR806

Supporting the recognition of October 2025 as "National Breast Cancer Awareness Month".

NJ SJR62

Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

NJ AJR148

Designates October of each year as "Menopause Awareness Month" October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

NJ AJR96

Proclaiming the months of October 2025 and October 2026 as Breast Cancer Awareness Months.

Similar Bills

TN SB1382

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.

TN HB0858

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.

IN HB1114

Coverage for certain cancer prescriptions.

IA SF197

A bill for an act relating to insurance coverage for prescription drugs used in the treatment of metastatic cancer and associated conditions.

PA HR49

Designating October 13, 2025, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.

TN HB1956

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.

TN SB2081

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.

IN HB1062

Coverage for certain cancer prescriptions.